Paper31769737
In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model.
Williams IP and 12 others. MAbs, 2020. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model. Papers, record 31769737. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31769737
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Neoplasm | Major topic |
| Antineoplastic Agents, Immunological | Major topic |
| Chondroitin Sulfate Proteoglycans | Major topic |
| Immunoglobulin E | Major topic |
| Membrane Proteins | Major topic |
| Recombinant Fusion Proteins | Major topic |
| Animals | |
| Antibody-Dependent Cell Cytotoxicity | |
| Cell Line, Tumor | |
| Cross Reactions | |
| Female | |
| Humans | |
| Immunization, Secondary | |
| Immunocompetence | |
| Mice | |
| Rats | |
| Chondroitin Sulfate Proteoglycan 4 |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MR/L023091/1 | Medical Research Council | United Kingdom | PubMed | |
| C30122/A15774 | Cancer Research UK | United Kingdom | PubMed | |
| C30122/A11527 | Cancer Research UK | United Kingdom | PubMed |
Source PubMed
References59
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29360527 | Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology. | J Allergy Clin Immunol | 2018 | https://conductscience.org/library/papers/29360527 | PubMed |
| 2 | 19767073 | Elevated serum cytokines during human anaphylaxis: Identification of potential mediators of acute allergic reactions. | J Allergy Clin Immunol | 2009 | https://conductscience.org/library/papers/19767073 | PubMed |
| 3 | 9816036 | Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma. | Clin Cancer Res | 1995 | https://conductscience.org/library/papers/9816036 | PubMed |
| 4 | 21569129 | Harnessing engineered antibodies of the IgE class to combat malignancy: initial assessment of FcɛRI-mediated basophil activation by a tumour-specific IgE antibody to evaluate the risk of type I hypersensitivity. | Clin Exp Allergy | 2011 | https://conductscience.org/library/papers/21569129 | PubMed |
| 5 | 22692757 | Using the allergic immune system to target cancer: activity of IgE antibodies specific for human CD20 and MUC1. | Cancer Immunol Immunother | 2012 | https://conductscience.org/library/papers/22692757 | PubMed |
| 6 | 31217827 | Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma. | Ther Adv Med Oncol | 2019 | https://conductscience.org/library/papers/31217827 | PubMed |
| 7 | 15531878 | Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. | Nature | 2004 | https://conductscience.org/library/papers/15531878 | PubMed |
| 8 | 21913827 | Analysis of patient survival in a Phase I trial of systemic targeted α-therapy for metastatic melanoma. | Immunotherapy | 2011 | https://conductscience.org/library/papers/21913827 | PubMed |
| 9 | 25197555 | Multiple chimeric antigen receptors successfully target chondroitin sulfate proteoglycan 4 in several different cancer histologies and cancer stem cells. | J Immunother Cancer | 2014 | https://conductscience.org/library/papers/25197555 | PubMed |
| 10 | 20406069 | Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. | Biomark Med | 2010 | https://conductscience.org/library/papers/20406069 | PubMed |
| 11 | 10903725 | Expression of a functional Fc epsilon RI on rat eosinophils and macrophages. | J Immunol | 2000 | https://conductscience.org/library/papers/10903725 | PubMed |
| 12 | 20395199 | A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas. | Cancer Res | 2010 | https://conductscience.org/library/papers/20395199 | PubMed |
| 13 | 15824037 | Differential arterial/venous expression of NG2 proteoglycan in perivascular cells along microvessels: identifying a venule-specific phenotype. | Microcirculation | 2005 | https://conductscience.org/library/papers/15824037 | PubMed |
| 14 | 28526770 | Therapeutic IgE Antibodies: Harnessing a Macrophage-Mediated Immune Surveillance Mechanism against Cancer. | Cancer Res | 2017 | https://conductscience.org/library/papers/28526770 | PubMed |
| 15 | 30956175 | IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural states. | EBioMedicine | 2019 | https://conductscience.org/library/papers/30956175 | PubMed |
| 16 | 1760821 | Regression of human melanoma xenografts in nude mice injected with methotrexate linked to monoclonal antibody 225.28 to human high molecular weight-melanoma associated antigen. | Cancer Immunol Immunother | 1991 | https://conductscience.org/library/papers/1760821 | PubMed |
| 17 | 31024519 | Biomarkers in Human Anaphylaxis: A Critical Appraisal of Current Evidence and Perspectives. | Front Immunol | 2019 | https://conductscience.org/library/papers/31024519 | PubMed |
| 18 | 9700724 | Tumor-specific IgE-mediated inhibition of human colorectal carcinoma xenograft growth. | Oncol Res | 1998 | https://conductscience.org/library/papers/9700724 | PubMed |
| 19 | 23594731 | A novel IgE antibody targeting the prostate-specific antigen as a potential prostate cancer therapy. | BMC Cancer | 2013 | https://conductscience.org/library/papers/23594731 | PubMed |
| 20 | 28096174 | Anti-Folate Receptor-α IgE but not IgG Recruits Macrophages to Attack Tumors via TNFα/MCP-1 Signaling. | Cancer Res | 2017 | https://conductscience.org/library/papers/28096174 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41672926 | AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes. | Clin Exp Allergy | 2026 | https://conductscience.org/library/papers/41672926 | PubMed |
| 41288857 | IgE based therapeutics are an emerging modality in cancer treatment. | Discov Oncol | 2025 | https://conductscience.org/library/papers/41288857 | PubMed |
| 40082557 | Human CSPG4-targeting CAR-macrophages inhibit melanoma growth. | Oncogene | 2025 | https://conductscience.org/library/papers/40082557 | PubMed |
| 39934835 | An IgE antibody targeting HER2 identified by clonal selection restricts breast cancer growth via immune-stimulating activities. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/39934835 | PubMed |
| 39833133 | Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production. | MAbs | 2025 | https://conductscience.org/library/papers/39833133 | PubMed |
| 39409881 | Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39409881 | PubMed |
| 38533720 | Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma. | Expert Rev Clin Immunol | 2024 | https://conductscience.org/library/papers/38533720 | PubMed |
| 38132155 | Therapeutic Monoclonal Antibodies against Cancer: Present and Future. | Cells | 2023 | https://conductscience.org/library/papers/38132155 | PubMed |
| 37491373 | Safety and anti-tumour activity of the IgE antibody MOv18 in patients with advanced solid tumours expressing folate receptor-alpha: a phase I trial. | Nat Commun | 2023 | https://conductscience.org/library/papers/37491373 | PubMed |
| 37185332 | Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4. | Nat Commun | 2023 | https://conductscience.org/library/papers/37185332 | PubMed |
| 36211808 | Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies. | Oncoimmunology | 2022 | https://conductscience.org/library/papers/36211808 | PubMed |
| 35718062 | A human IgE bispecific antibody shows potent cytotoxic capacity mediated by monocytes. | J Biol Chem | 2022 | https://conductscience.org/library/papers/35718062 | PubMed |
| 35433433 | Harnessing the Anti-Tumor Mediators in Mast Cells as a New Strategy for Adoptive Cell Transfer for Cancer. | Front Oncol | 2022 | https://conductscience.org/library/papers/35433433 | PubMed |
| 34513315 | In vivo trafficking of a tumor-targeting IgE antibody: molecular imaging demonstrates rapid hepatobiliary clearance compared to IgG counterpart. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/34513315 | PubMed |
| 33155272 | Isotype selection for antibody-based cancer therapy. | Clin Exp Immunol | 2021 | https://conductscience.org/library/papers/33155272 | PubMed |
| 33081206 | IgE Antibodies against Cancer: Efficacy and Safety. | Antibodies (Basel) | 2020 | https://conductscience.org/library/papers/33081206 | PubMed |
| 32331483 | A Novel Antibody-Drug Conjugate (ADC) Delivering a DNA Mono-Alkylating Payload to Chondroitin Sulfate Proteoglycan (CSPG4)-Expressing Melanoma. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32331483 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGT | 183 | PubTator's text mining | https://conductscience.org/library/genes/183 | NCBI Gene |
| CSPG4 | 1464 | PubTator's text mining | https://conductscience.org/library/genes/1464 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| FCER1A | 2205 | PubTator's text mining | https://conductscience.org/library/genes/2205 | NCBI Gene |
| FOSL1 | 8061 | PubTator's text mining | https://conductscience.org/library/genes/8061 | NCBI Gene |
| IGHE | 3497 | PubTator's text mining | https://conductscience.org/library/genes/3497 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31769737
GET https://conductscience.org/api/papers/v1/31769737/references?page=2